Spots Global Cancer Trial Database for Register of Blood Stem Cell Transplantation

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Register of Blood Stem Cell Transplantation

Official Title: Register of Survey and Evaluation of Blood Stem Cell Transplantations of Clinic III of Internal Medicine III

Study ID: NCT04263857

Conditions

Hematologic Malignancies

Interventions

Study Description

Brief Summary: Register of patients with blood stem cell transplantations (autologous, allogen).

Detailed Description: Documenting the success rate in terms of complication rate, disease response, survival rate, engraftment, and details of transplantation settings, for example donor and conditioning data, remission status before transplantation. It's a register of patients who have one or more autologous and / or allogenic blood stem cell transplants due to an existing indication for performing myeloablative / non-myeloablative high-dose chemotherapy. The inclusion occurs at our center during preparation for blood stem cell transplantation. The written consent will be obtained separately in the context of the information on blood stem cell transplantation. Participation is voluntary and consent can be revoked at any time. This involves no additional effort for the patient and has no influence on his treatment. It may be necessary in the course of contacting the patient at home, as long as the data is incomplete. This is also explicitly explained. A copy of the declaration of consent is given to the patient.